Executive summary: Japanese guidelines for adult asthma (JGL) 2021
Allergology International · 2023
DOI: 10.1016/j.alit.2023.02.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Allergology International, 2023. Verfasst von Akio Niimi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Elect…. Hauptthemen laut MEDLINE: Asthma, Pulmonary Disease, Chronic Obstructive, Anti-Asthmatic Agents. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Asthma is characterized by chronic airway inflammation, variable airway narrowing, and sensory nerve irritation, which manifest as wheezing, dyspnea, chest tightness, and cough. Longstanding asthma may result in airway remodeling and become intractable. Despite the increased prevalence of asthma in adults, asthma-associated deaths have decreased in Japan (0.94 per 100,000 people in 2020). The goals of asthma treatment include the control of symptoms and reduction of future risks. A functional partnership between physicians and patients is indispensable for achieving these goals. Long-term management with medications and the elimination of triggers and risk factors are fundamental to asthma treatment. Asthma is managed via four steps of pharmacotherapy ("controllers"), ranging from mild to intensive treatments, depending on disease severity; each step involves daily administration of an inhaled corticosteroid, which varies from low to high dosage. Long-acting β2 agonists, leukotriene receptor antagonists, sustained-release theophylline, and long-acting muscarinic antagonists are recommended as add-on drugs. Allergen immunotherapy is a new option that is employed as a controller treatment. Further, as of 2021, anti-IgE antibody, anti-IL-5 and anti-IL-5 receptor α-chain antibodies, and anti-IL-4 receptor α-chain antibodies are available for the treatment of severe asthma. Bronchial thermoplasty can be performed for asthma treatment, and its long-term efficacy has been reported. Algorithms for their usage have been revised. Comorbidities, such as allergic rhinitis, chronic rhinosinusitis, chronic obstructive pulmonary disease, and aspirin-exacerbated respiratory disease, should also be considered during the treatment of chronic asthma. Depending on the severity of episodes, inhaled short-acting β2 agonists, systemic corticosteroids, short-acting muscarinic antagonists, oxygen therapy, and other approaches are used as needed ("relievers") during exacerbation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Electronic address: a.niimi@med.nagoya-cu.ac.jp.
- Pulmonary Division, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
- Center for Immunology and Allergology, Shonan Kamakura General Hospital, Kanagawa, Japan.
- Medical Center for Allergic and Immune Diseases, Yokohama City Minato Red Cross Hospital, Yokohama, Japan.
- Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.
- Department of Respiratory Medicine, Toyota Regional Medical Center, Toyota, Japan.
Zitieren
APA
Niimi, A., Fukunaga, K., Taniguchi, M., Nakamura, Y., Tagaya, E., Horiguchi, T., Yokoyama, A., Yamaguchi, M., & Nagata, M. (2023). Executive summary: Japanese guidelines for adult asthma (JGL) 2021. Allergology International. https://doi.org/10.1016/j.alit.2023.02.006
Vancouver
Niimi A, Fukunaga K, Taniguchi M, Nakamura Y, Tagaya E, Horiguchi T, et al. Executive summary: Japanese guidelines for adult asthma (JGL) 2021. Allergology International. 2023. doi:10.1016/j.alit.2023.02.006
BibTeX
@article{Niimi2023,
author = {Niimi, Akio and Fukunaga, Koichi and Taniguchi, Masami and Nakamura, Yoichi and Tagaya, Etsuko and Horiguchi, Takahiko and Yokoyama, Akihito and Yamaguchi, Masao and Nagata, Makoto},
title = {Executive summary: Japanese guidelines for adult asthma (JGL) 2021},
journal = {Allergology International},
year = {2023},
doi = {10.1016/j.alit.2023.02.006}
}
EUVIMED